Stay informed with free updates Simply register at Pharmaceutical sector myFT Digest – delivered straight to your inbox. Alphaville has received a LOT of research on stocks related to the impact of weight loss drugs such as Ozempic* and Wegovy (mainFT has a great overview here). As the power of… Continue Reading Can weight loss drugs save the aviation industry (some money)?
Weight loss medications have grown in popularity in recent years. People even use a drug like Ozempic, although it is only approved for diabetes, simply because it helps them lose weight. In the last three months of 2022 alone, more than 9 million prescriptions for weight loss drugs were dispensed… Continue Reading 1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool
Eye-popping predictions for weight-loss drug sales hinge on insurance companies agreeing to provide coverage for expensive treatments, and momentum appears to be building on that front. But Allen Lutz, an analyst at Bank of America, wonders if employers know how risky the bet they’re making is. The hope is that… Continue Reading Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases